Product In Development
Payments companies reported to CMS as associated with Product In Development. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Product In Development, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Product In Development
These are the largest totals companies reported as associated with Product In Development. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Esen Akpek | Baltimore, MD | Ophthalmology | $517,629.95 |
| Gagan Singh | Sacramento, CA | Cardiovascular Disease | $114,632.10 |
| David Barack | Skokie, IL | Periodontics | $101,274.00 |
| Dennis Hammond | Grand Rapids, MI | Plastic Surgery | $78,947.54 |
| Priya Mathews | Venice, FL | Cornea and External Diseases Specialist | $71,403.61 |
| Sukgu Han | Los Angeles, CA | Vascular Surgery | $70,832.44 |
| Maria Cortina | Chicago, IL | Ophthalmology | $68,327.51 |
| Mark Morasch | Springfield, OR | Vascular Surgery | $67,430.00 |
| Thomas Smith | Sacramento, CA | Cardiovascular Disease | $59,910.63 |
| Joseph Bavaria | Allentown, PA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $59,458.20 |
Prescribed Product In Development?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.